Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The case for treating mild hypertension.

M Moser

    Journal of Cardiovascular Pharmacology
    |January 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Lowering high blood pressure (hypertension) to normal levels significantly reduces mortality and morbidity. This is true even for mild hypertension, according to extensive clinical trial data.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Selection based on morphological assessment of oocytes and embryos at different stages of preimplantation development: a review.

    Human reproduction update·2003
    Same author

    Developmental competence of oocytes showing increased cytoplasmic viscosity.

    Human reproduction (Oxford, England)·2003
    Same author

    Signal recognition particle-dependent protein targeting, universal to all kingdoms of life.

    Reviews of physiology, biochemistry and pharmacology·2003
    Same author

    [Otorhinolaryngologic diseases and flying].

    Wiener medizinische Wochenschrift (1946)·2002
    Same author

    First polar body morphology and blastocyst formation rate in ICSI patients.

    Human reproduction (Oxford, England)·2002
    Same author

    Prospective hatching of embryos developed from oocytes exhibiting difficult oolemma penetration during ICSI.

    Human reproduction (Oxford, England)·2002
    Same journal

    SGLT2 Inhibitors and Progression of Chronic Kidney Disease in Patients with Elevated Lipoprotein(a): A Real-World Cohort Study.

    Journal of cardiovascular pharmacology·2026
    Same journal

    Aspirin in primary prevention: a case for selective use.

    Journal of cardiovascular pharmacology·2026
    Same journal

    Expert Opinion: Restrictions, Precautions, or Normalcy? Defining Everyday Risk in Patients Treated With IL-1 Blockers for Recurrent Pericarditis.

    Journal of cardiovascular pharmacology·2026
    Same journal

    The Therapeutic Role of Exercise in Diabetic Cardiomyopathy: Underlying Mechanisms and Interactions with Antidiabetic Medications.

    Journal of cardiovascular pharmacology·2026
    Same journal

    Cardiovascular Adverse Events Associated with Immune Checkpoint Inhibitors from the Perspective of Gut Microecology: Potential Roles and Research Advances of the Gut Microbiota.

    Journal of cardiovascular pharmacology·2026
    Same journal

    Silencing Triglycerides: The Clinical Impact of Plozasiran and apoC-III Inhibition in Severe Hypertriglyceridemia.

    Journal of cardiovascular pharmacology·2026
    See all related articles

    Area of Science:

    • Cardiology
    • Public Health
    • Hypertension Research

    Background:

    • Elevated blood pressure (hypertension) poses significant health risks.
    • Previous research established treatment benefits for severe hypertension.
    • Recent guidelines recommend lowering blood pressure above 140/90 mm Hg.

    Purpose of the Study:

    • To review data supporting current hypertension treatment guidelines.
    • To assess the impact of blood pressure lowering on mortality and morbidity.
    • To evaluate treatment efficacy across different hypertension severity levels.

    Main Methods:

    • Review of major clinical trials and extensive data from the past 15-20 years.
    • Analysis of findings from U.S. Public Health Service Study and HDFP Study.

    Related Experiment Videos

  • Inclusion of data from the Australian Study in Mild Hypertension.

    • Main Results:

    • Blood pressure lowering reduces mortality and morbidity, even in mild hypertension (diastolic BPs 90-104 mm Hg).
    • Effective blood pressure management leads to normotensive levels (<140/90 mm Hg).
    • Studies show decreased cerebrovascular events and a trend towards reduced cardiovascular mortality.

    Conclusions:

    • Consistently elevated blood pressure above 140/90 mm Hg in adults should be lowered.
    • Blood pressure reduction is beneficial across the spectrum of hypertension, including mild cases.
    • Effective hypertension management improves patient outcomes and reduces cardiovascular risks.